5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.90▲ | 0.93▼ | 0.92▼ | 0.91▲ | 0.87▲ |
MA10 | 0.93▼ | 0.91▲ | 0.89▲ | 0.89▲ | 0.78▲ |
MA20 | 0.92▼ | 0.93▼ | 0.94▼ | 0.85▲ | 0.68▲ |
MA50 | 0.96▼ | 0.93▼ | 0.90▲ | 0.71▲ | 1.02▼ |
MA100 | 0.94▼ | 0.87▲ | 0.84▲ | 0.64▲ | 0.62▲ |
MA200 | 0.91▲ | 0.78▲ | 0.72▲ | 1.22▼ | 0.67▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | -0.001▼ | -0.004▼ | -0.001▼ | 0.055▲ |
RSI | 48.259▼ | 49.375▼ | 50.729▲ | 58.358▲ | 55.642▲ |
STOCH | 31.859 | 25.219 | 20.276 | 33.777 | 67.140 |
WILL %R | -54.587 | -78.125▼ | -78.125▼ | -60.924 | -36.149 |
CCI | -22.133 | 12.620 | -3.994 | 156.007▲ | 124.771▲ |
Friday, June 06, 2025 01:13 PM
Matinas BioPharma, Inc. (NYSE:MTNB) operates in the clinical-stage biopharmaceutical sector and is listed on the NYSE Composite.
|
Sunday, May 04, 2025 05:00 PM
Matinas Biopharma has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, Marker Therapeutics has a beta of 1.29, indicating that its stock price ...
|
Monday, April 21, 2025 05:00 PM
1 Day MTNB 7.68% DJIA 2.66% Russell 2K 2.71% Health Care/Life Sciences 0.24% ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 0.84 | 1.1899 | 0.8399 | 0.9314 | 4,190,560 |
13/06/25 | 0.8323 | 0.8699 | 0.8323 | 0.84 | 66,947 |
12/06/25 | 0.9672 | 1.00 | 0.8601 | 0.88 | 160,640 |
11/06/25 | 0.88 | 1.08 | 0.88 | 1.04 | 845,373 |
10/06/25 | 0.8842 | 0.8842 | 0.8826 | 0.8826 | 74,991 |
09/06/25 | 0.94 | 0.957 | 0.8606 | 0.88 | 117,059 |
06/06/25 | 0.862 | 0.943 | 0.852 | 0.9299 | 137,297 |
05/06/25 | 0.85 | 0.96 | 0.81 | 0.8772 | 321,895 |
04/06/25 | 0.80 | 0.86 | 0.792 | 0.83 | 185,200 |
03/06/25 | 0.82 | 1.1697 | 0.7722 | 0.8076 | 3,265,616 |
|
|
||||
|
|
||||
|
|